FORTITUDE Clinical Trials
The FORTITUDE-101 and FORTITUDE-102 trials are currently enrolling adults with previously untreated advanced or metastatic stomach or gastroesophageal junction (GEJ) cancer.
MOUNTAINEER Trial
MOUNTAINEER is a phase II trial for people diagnosed with metastatic HER2-positive colorectal cancer or HER2-positive disease that can’t be completely removed with surgery.